These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 21168673)
21. Safety and efficacy of once-daily modified-release tacrolimus in kidney transplant recipients: interim analysis of multicenter postmarketing surveillance in Japan. Takahashi K; Abe R; Usuki S; So M Transplant Proc; 2014; 46(2):406-10. PubMed ID: 24655975 [TBL] [Abstract][Full Text] [Related]
22. Successful conversion from twice-daily to once-daily tacrolimus in liver transplantation: observational multicenter study. Dopazo C; Rodriguez R; Llado L; Calatayud D; Castells L; Ramos E; Molina V; García R; Fabregat J; Charco R Clin Transplant; 2012; 26(1):E32-7. PubMed ID: 21958123 [TBL] [Abstract][Full Text] [Related]
23. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus. Fairbanks KD; Eustace JA; Fine D; Thuluvath PJ Liver Transpl; 2003 Oct; 9(10):1079-85. PubMed ID: 14526403 [TBL] [Abstract][Full Text] [Related]
24. Calcineurin inhibitor-induced headache: clinical characteristics and possible mechanisms. Ferrari U; Empl M; Kim KS; Sostak P; Förderreuther S; Straube A Headache; 2005 Mar; 45(3):211-4. PubMed ID: 15836594 [TBL] [Abstract][Full Text] [Related]
25. Treatment satisfaction in renal transplant patients taking tacrolimus once daily. van Boekel GA; Kerkhofs CH; Hilbrands LB Clin Ther; 2013 Nov; 35(11):1821-9.e1. PubMed ID: 24135441 [TBL] [Abstract][Full Text] [Related]
26. Magnesium-deficiency does not alter calcineurin inhibitors activity in mice. Hulin A; Lamrani L; Sabbagh F; Tallet A; Lecerf F; Bac P; German-Fattal M Transpl Immunol; 2012 Jan; 26(1):55-61. PubMed ID: 21964379 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results. Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M; Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208 [TBL] [Abstract][Full Text] [Related]
28. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF; Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978 [TBL] [Abstract][Full Text] [Related]
29. Conversion of heart transplant patients from standard to sustained-release tacrolimus requires a dosage increase. Marzoa-Rivas R; Paniagua-Martín MJ; Barge-Caballero E; Pedrosa del Moral V; Barge-Caballero G; Grille-Cancela Z; Naya-Leira C; Fariñas-Garrido P; Blanco-Canosa P; Mosquera V; Castro-Beiras A; Crespo-Leiro MG Transplant Proc; 2010 Oct; 42(8):2994-6. PubMed ID: 20970591 [TBL] [Abstract][Full Text] [Related]
30. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study. Pacor ML; Di Lorenzo G; Martinelli N; Mansueto P; Rini GB; Corrocher R Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of tacrolimus versus cyclosporine microemulsion in primary cardiac transplant recipients: 6-month results in Taiwan. Wang CH; Ko WJ; Chou NK; Wang SS Transplant Proc; 2004 Oct; 36(8):2384-5. PubMed ID: 15561256 [TBL] [Abstract][Full Text] [Related]
32. Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients. Florman S; Alloway R; Kalayoglu M; Punch J; Bak T; Melancon J; Klintmalm G; Busque S; Charlton M; Lake J; Dhadda S; Wisemandle K; Wirth M; Fitzsimmons W; Holman J; First MR Transplantation; 2007 Jun; 83(12):1639-42. PubMed ID: 17589349 [TBL] [Abstract][Full Text] [Related]
33. Influence of early posttransplantation prednisone and calcineurin inhibitor dosages on the incidence of new-onset diabetes. Burroughs TE; Lentine KL; Takemoto SK; Swindle J; Machnicki G; Hardinger K; Brennan DC; Irish WD; Schnitzler MA Clin J Am Soc Nephrol; 2007 May; 2(3):517-23. PubMed ID: 17699459 [TBL] [Abstract][Full Text] [Related]
34. Calcineurin inhibitor dose-finding before kidney transplantation in HIV patients. Pulzer A; Seybold U; Schönermarck U; Stangl M; Habicht A; Bogner JR; Franke J; Fischereder M Transpl Int; 2013 Mar; 26(3):254-8. PubMed ID: 23227980 [TBL] [Abstract][Full Text] [Related]
35. Two-year experience with tacrolimus in renal transplantation after late conversion from cyclosporine therapy. Videla CO Transplant Proc; 2009; 41(6):2659-63. PubMed ID: 19715995 [TBL] [Abstract][Full Text] [Related]
36. Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients. Alloway R; Steinberg S; Khalil K; Gourishankar S; Miller J; Norman D; Hariharan S; Pirsch J; Matas A; Zaltzman J; Wisemandle K; Fitzsimmons W; First MR Transplantation; 2007 Jun; 83(12):1648-51. PubMed ID: 17589351 [TBL] [Abstract][Full Text] [Related]
37. Calcineurin inhibitors and post-transplant weight gain. Ersoy A; Baran B; Ersoy C; Kahvecioglu S; Akdag I Nephrology (Carlton); 2008 Oct; 13(5):433-9. PubMed ID: 18331443 [TBL] [Abstract][Full Text] [Related]
38. Evolution to twice daily bolus intravenous tacrolimus: optimizing efficacy and safety of calcineurin inhibitor delivery early post lung transplant. Snell GI; Ivulich S; Mitchell L; Westall GP; Levvey BJ Ann Transplant; 2013 Aug; 18():399-407. PubMed ID: 23921892 [TBL] [Abstract][Full Text] [Related]
39. Differential effects of acute and sustained cyclosporine and tacrolimus on sympathetic nerve activity. Klein IH; Abrahams AC; van Ede T; Oey PL; Ligtenberg G; Blankestijn PJ J Hypertens; 2010 Sep; 28(9):1928-34. PubMed ID: 20577127 [TBL] [Abstract][Full Text] [Related]
40. ACE gene D/D genotype as a risk factor for chronic nephrotoxicity from calcineurin inhibitors in liver transplant recipients. Gallon L; Akalin E; Lynch P; Rothberg L; Parker M; Schiano T; Abecassis M; Murphy B Transplantation; 2006 Feb; 81(3):463-8. PubMed ID: 16477235 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]